Skip to main content
Erschienen in: International Urology and Nephrology 2/2017

28.11.2016 | Urology - Original Paper

Modified laparoscopic simple enucleation with single-layer suture technique versus standard laparoscopic partial nephrectomy for treating localized renal cell carcinoma

verfasst von: Qun Lu, Xiaozhi Zhao, Changwei Ji, Suhan Guo, Guangxiang Liu, Shiwei Zhang, Xiaogong Li, Weidong Gan, Hongqian Guo

Erschienen in: International Urology and Nephrology | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To compare modified laparoscopic simple enucleation (MLSE) and standard laparoscopic partial nephrectomy (SLPN) for treating localized renal cell carcinoma in our large institutional experience.

Methods

We evaluated 385 consecutive patients who underwent MLSE or SLPN for renal tumors in our institution from January 2013 to December 2015 in terms of perioperative pathological and oncologic outcome variables. During MLSE, the single-layer suture technique was performed for renal reconstruction.

Results

In total, 280 patients underwent MLSE and 105 underwent SLPN. Mean operative time was 182.1 and 192.8 min, respectively (p = 0.078). Warm ischemic time was significantly lower in the MLSE than SLPN group (23.2 vs 25.4 min; p = 0.004). The estimated blood loss was similar (p = 0.537). Tumor bed suturing was performed in 9.3 and 82.9% of MLSE and SLPN cases (p = 0.000). No hilar clamping was needed for 29 MLSE patients (10.4%) and 4 SLPN patients (3.8%) (p = 0.041). Grade III complications were reported in 5 (1.8%) MLSE patients and 7 (6.6%) SLPN patients (p = 0.034). The incidence of positive surgical margins was comparable between the MLSE and SLPN groups (1.8 and 5.7%, p = 0.086). After a median follow-up of 18 months, recurrence did not differ between the 2 groups: 9 (3.2%) MLSE patients and 4 (3.8%) SLPN patients (p = 1.000).

Conclusions

MLSE may confer shorter warm ischemic time, almost no need for tumor bed suturing and less grade III complications than SLPN, with similar oncologic outcomes. MLSE may be safe and acceptable for patients undergoing partial nephrectomy.
Literatur
1.
Zurück zum Zitat Ljungberg B, Bensalah K, Canfield S et al (2015) EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 67(5):913–924CrossRefPubMed Ljungberg B, Bensalah K, Canfield S et al (2015) EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 67(5):913–924CrossRefPubMed
2.
Zurück zum Zitat Bhatt JR, Finelli A (2014) Landmarks in the diagnosis and treatment of renal cell carcinoma. Nat Rev Urol 11(9):517–525CrossRefPubMed Bhatt JR, Finelli A (2014) Landmarks in the diagnosis and treatment of renal cell carcinoma. Nat Rev Urol 11(9):517–525CrossRefPubMed
3.
Zurück zum Zitat Ljungberg B, Hanbury DC, Kuczyk MA et al (2007) Renal cell carcinoma guideline. Eur Urol 51(6):1502–1510CrossRefPubMed Ljungberg B, Hanbury DC, Kuczyk MA et al (2007) Renal cell carcinoma guideline. Eur Urol 51(6):1502–1510CrossRefPubMed
4.
Zurück zum Zitat Antonelli A, Cozzoli A, Nicolai M et al (2008) Nephron-sparing surgery versus radical nephrectomy in the treatment of intracapsular renal cell carcinoma up to 7 cm. Eur Urol 53(4):803–809CrossRefPubMed Antonelli A, Cozzoli A, Nicolai M et al (2008) Nephron-sparing surgery versus radical nephrectomy in the treatment of intracapsular renal cell carcinoma up to 7 cm. Eur Urol 53(4):803–809CrossRefPubMed
5.
Zurück zum Zitat Li QL, Guan HW, Zhang QP et al (2003) Optimal margin in nephron-sparing surgery for renal cell carcinoma 4 cm or less. Eur Urol 44(4):448–451CrossRefPubMed Li QL, Guan HW, Zhang QP et al (2003) Optimal margin in nephron-sparing surgery for renal cell carcinoma 4 cm or less. Eur Urol 44(4):448–451CrossRefPubMed
6.
Zurück zum Zitat Puppo P, Introini C, Calvi P et al (2004) Long term results of excision of small renal cancer surrounded by a minimal layer of grossly normal parenchyma: review of 94 cases. Eur Urol 46(4):477–481CrossRefPubMed Puppo P, Introini C, Calvi P et al (2004) Long term results of excision of small renal cancer surrounded by a minimal layer of grossly normal parenchyma: review of 94 cases. Eur Urol 46(4):477–481CrossRefPubMed
7.
Zurück zum Zitat Castilla EA, Liou LS, Abrahams NA et al (2002) Prognostic importance of resection margin width after nephron-sparing surgery for renal cell carcinoma. Urology 60(6):993–997CrossRefPubMed Castilla EA, Liou LS, Abrahams NA et al (2002) Prognostic importance of resection margin width after nephron-sparing surgery for renal cell carcinoma. Urology 60(6):993–997CrossRefPubMed
8.
Zurück zum Zitat Lane BR, Campbell SC, Gill IS (2013) 10-year oncologic outcomes after laparoscopic and open partial nephrectomy. J Urol 190(1):44–49CrossRefPubMed Lane BR, Campbell SC, Gill IS (2013) 10-year oncologic outcomes after laparoscopic and open partial nephrectomy. J Urol 190(1):44–49CrossRefPubMed
9.
Zurück zum Zitat Minervini A, Ficarra V, Rocco F et al (2011) Simple enucleation is equivalent to traditional partial nephrectomy for renal cell carcinoma: results of a nonrandomized, retrospective, comparative study. J Urol 185(5):1604–1610CrossRefPubMed Minervini A, Ficarra V, Rocco F et al (2011) Simple enucleation is equivalent to traditional partial nephrectomy for renal cell carcinoma: results of a nonrandomized, retrospective, comparative study. J Urol 185(5):1604–1610CrossRefPubMed
10.
Zurück zum Zitat Longo N, Minervini A, Antonelli A et al (2014) Simple enucleation versus standard partial nephrectomy for clinical T1 renal masses: perioperative outcomes based on a matched-pair comparison of 396 patients (RECORd project). Eur J Surg Oncol 40(6):762–768CrossRefPubMed Longo N, Minervini A, Antonelli A et al (2014) Simple enucleation versus standard partial nephrectomy for clinical T1 renal masses: perioperative outcomes based on a matched-pair comparison of 396 patients (RECORd project). Eur J Surg Oncol 40(6):762–768CrossRefPubMed
11.
Zurück zum Zitat Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649–655CrossRefPubMed Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649–655CrossRefPubMed
12.
Zurück zum Zitat Patard JJ, Leray E, Cindolo L et al (2004) Multi-institutional validation of a symptom based classification for renal cell carcinoma. J Urol 172(3):858–862CrossRefPubMed Patard JJ, Leray E, Cindolo L et al (2004) Multi-institutional validation of a symptom based classification for renal cell carcinoma. J Urol 172(3):858–862CrossRefPubMed
13.
Zurück zum Zitat Ficarra V, Novara G, Secco S et al (2009) Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery. Eur Urol 56(5):786–793CrossRefPubMed Ficarra V, Novara G, Secco S et al (2009) Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery. Eur Urol 56(5):786–793CrossRefPubMed
14.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213CrossRefPubMedPubMedCentral Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Minervini A, Serni S, Tuccio A et al (2012) Simple enucleation versus radical nephrectomy in the treatment of pT1a and pT1b renal cell carcinoma. Ann Surg Oncol 19(2):694–700CrossRefPubMed Minervini A, Serni S, Tuccio A et al (2012) Simple enucleation versus radical nephrectomy in the treatment of pT1a and pT1b renal cell carcinoma. Ann Surg Oncol 19(2):694–700CrossRefPubMed
16.
Zurück zum Zitat Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17(6):1471–1474CrossRefPubMed Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17(6):1471–1474CrossRefPubMed
17.
Zurück zum Zitat Kovacs G, Akhtar M, Beckwith BJ et al (1997) The Heidelberg classification of renal cell tumours. J Pathol 183(2):131–133CrossRefPubMed Kovacs G, Akhtar M, Beckwith BJ et al (1997) The Heidelberg classification of renal cell tumours. J Pathol 183(2):131–133CrossRefPubMed
18.
Zurück zum Zitat Fuhrman SA, Lasky LC, Limas C (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6(7):655–663CrossRefPubMed Fuhrman SA, Lasky LC, Limas C (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6(7):655–663CrossRefPubMed
19.
Zurück zum Zitat Gill IS, Kavoussi LR, Lane BR et al (2007) Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol 178(1):41–46CrossRefPubMed Gill IS, Kavoussi LR, Lane BR et al (2007) Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol 178(1):41–46CrossRefPubMed
20.
Zurück zum Zitat Campbell SC, Novick AC, Belldegrun A et al (2009) Guideline for management of the clinical T1 renal mass. J Urol 182(4):1271–1279CrossRefPubMed Campbell SC, Novick AC, Belldegrun A et al (2009) Guideline for management of the clinical T1 renal mass. J Urol 182(4):1271–1279CrossRefPubMed
21.
Zurück zum Zitat Jeong SJ, Kim KT, Chung MS et al (2010) The prognostic value of the width of the surgical margin in the enucleoresection of small renal cell carcinoma: an intermediate-term follow-up. Urology 76(3):587–592CrossRefPubMed Jeong SJ, Kim KT, Chung MS et al (2010) The prognostic value of the width of the surgical margin in the enucleoresection of small renal cell carcinoma: an intermediate-term follow-up. Urology 76(3):587–592CrossRefPubMed
22.
Zurück zum Zitat Azhar RA, de Castro Abreu A L, Broxham E et al (2015) Histological analysis of the kidney tumor-parenchyma interface. J Urol 193(2):415–422CrossRefPubMed Azhar RA, de Castro Abreu A L, Broxham E et al (2015) Histological analysis of the kidney tumor-parenchyma interface. J Urol 193(2):415–422CrossRefPubMed
23.
24.
Zurück zum Zitat Rosenthal CL, Kraft R, Zingg EJ (1984) Organ-preserving surgery in renal cell carcinoma: tumor enucleation versus partial kidney resection. Eur Urol 10(4):222–228PubMed Rosenthal CL, Kraft R, Zingg EJ (1984) Organ-preserving surgery in renal cell carcinoma: tumor enucleation versus partial kidney resection. Eur Urol 10(4):222–228PubMed
25.
Zurück zum Zitat Minervini A, di Cristofano C, Lapini A et al (2009) Histopathologic analysis of peritumoral pseudocapsule and surgical margin status after tumor enucleation for renal cell carcinoma. Eur Urol 55(6):1410–1418CrossRefPubMed Minervini A, di Cristofano C, Lapini A et al (2009) Histopathologic analysis of peritumoral pseudocapsule and surgical margin status after tumor enucleation for renal cell carcinoma. Eur Urol 55(6):1410–1418CrossRefPubMed
26.
Zurück zum Zitat Marszalek M, Carini M, Chlosta P et al (2012) Positive surgical margins after nephron-sparing surgery. Eur Urol 61(4):757–763CrossRefPubMed Marszalek M, Carini M, Chlosta P et al (2012) Positive surgical margins after nephron-sparing surgery. Eur Urol 61(4):757–763CrossRefPubMed
27.
Zurück zum Zitat Pasticier G, Timsit MO, Badet L et al (2006) Nephron-sparing surgery for renal cell carcinoma: detailed analysis of complications over a 15-year period. Eur Urol 49(3):485–490CrossRefPubMed Pasticier G, Timsit MO, Badet L et al (2006) Nephron-sparing surgery for renal cell carcinoma: detailed analysis of complications over a 15-year period. Eur Urol 49(3):485–490CrossRefPubMed
Metadaten
Titel
Modified laparoscopic simple enucleation with single-layer suture technique versus standard laparoscopic partial nephrectomy for treating localized renal cell carcinoma
verfasst von
Qun Lu
Xiaozhi Zhao
Changwei Ji
Suhan Guo
Guangxiang Liu
Shiwei Zhang
Xiaogong Li
Weidong Gan
Hongqian Guo
Publikationsdatum
28.11.2016
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 2/2017
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-016-1470-1

Weitere Artikel der Ausgabe 2/2017

International Urology and Nephrology 2/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.